50 results on '"Avitabile, Emma"'
Search Results
2. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
3. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
4. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
5. Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis
6. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis
7. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery
8. OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis
9. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement
10. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
11. Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites
12. Beneficial effects of a screening programme for alcohol-related liver fibrosis with transient elastography in people with alcohol use disorder promoting alcohol abstinence
13. Natural history of hepatic steatosis associated to metabolic syndrome. Longitudinal study with 5 years of follow-up.
14. Prospective evaluation of the EASL clinical guidelines algorithm of management of acute kidney injury in cirrhosis
15. Quality of life in patients with advanced cirrhosis. Relationship with the development of complications
16. Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome
17. Improving NIAAA criteria for the diagnosis of alcoholic hepatitis, role of systemic inflammation
18. STIGMATIZATION IS COMMON IN PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE AND CORRELATES WITH QUALITY OF LIFE
19. Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis
20. Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes
21. Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome
22. Ammonium quantification in human plasma by proton nuclear magnetic resonance for staging of liver fibrosis in alcohol‐related liver disease and nonalcoholic fatty liver disease
23. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life
24. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome
25. Sex-Associated Differences in the Modulation of Vascular Risk in Patients with Asymptomatic Carotid Stenosis
26. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
27. Cognitive Deterioration in Bilateral Asymptomatic Severe Carotid Stenosis
28. Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study
29. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery
30. FRI-437 - Beneficial effects of a screening programme for alcohol-related liver fibrosis with transient elastography in people with alcohol use disorder promoting alcohol abstinence
31. FRI-431 - Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites
32. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis
33. Lack of evidence of significant tubular injury in patients with cirrhosis and persistent hepatorenal syndrome. implications for liver transplantation
34. Delisting of liver transplant candidates after improvement in alcohol-related decompensated cirrhosis: a multicentric study on incidence and outcomes
35. SAT524 - Prospective evaluation of the EASL clinical guidelines algorithm of management of acute kidney injury in cirrhosis
36. SAT522 - Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome
37. FRI244 - STIGMATIZATION IS COMMON IN PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE AND CORRELATES WITH QUALITY OF LIFE
38. FRI243 - Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis
39. FRI242 - Quality of life in patients with advanced cirrhosis. Relationship with the development of complications
40. THU039 - Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes
41. THU033 - Improving NIAAA criteria for the diagnosis of alcoholic hepatitis, role of systemic inflammation
42. OS080 - Natural history of hepatic steatosis associated to metabolic syndrome. Longitudinal study with 5 years of follow-up.
43. The Use of Rifaximin in Patients With Cirrhosis.
44. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
45. SAT107 - Lack of evidence of significant tubular injury in patients with cirrhosis and persistent hepatorenal syndrome. implications for liver transplantation
46. THU072 - Delisting of liver transplant candidates after improvement in alcohol-related decompensated cirrhosis: a multicentric study on incidence and outcomes
47. THU066 - Non-invasive criteria for diagnosis of alcoholic hepatitis: use in clinical practice and correlation with prognosis
48. Cognitive Deterioration in Bilateral Asymptomatic Severe Carotid Stenosis
49. Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support.
50. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.